# Piotr Rutkowski

Source: https://onco.cc/people/piotr-rutkowski/  
OnCo record `piotr-rutkowski` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Polish surgical oncologist who led the pooled EORTC and SWOG trials showing that imatinib shrinks dermatofibrosarcoma protuberans, a rare skin sarcoma driven by a PDGFB fusion.

## Summary

Piotr Rutkowski heads the department of soft tissue and bone sarcoma and melanoma at the National Research Institute of Oncology in Warsaw. He was first author of the 2010 Journal of Clinical Oncology report pooling the EORTC and SWOG phase 2 trials of imatinib in locally advanced or metastatic dermatofibrosarcoma protuberans, which established the drug for unresectable disease. He is a leading investigator in European melanoma and GIST trials.

## Fields

- Kind: Person
- Last checked: 2026-09-18
- Tags: sarcoma; melanoma; surgery; trialist
- Role: Surgical oncologist and head of soft tissue, bone sarcoma and melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw
- Specialisms: Melanoma; Sarcoma and GIST; Dermatofibrosarcoma protuberans

## Connected records

- cancers: [Dermatofibrosarcoma protuberans](https://onco.cc/cancers/dermatofibrosarcoma-protuberans/), [Gastrointestinal stromal tumour (GIST)](https://onco.cc/cancers/gist/), [Melanoma](https://onco.cc/cancers/melanoma/), [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)
- institutions: [Maria Skłodowska-Curie National Research Institute of Oncology](https://onco.cc/institutions/nio-warsaw/)
- key papers: [Imatinib in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase 2 trials (EORTC 62027 and SWOG S0345)](https://onco.cc/key-papers/paper-imatinib-dfsp-eortc-swog-rutkowski-jco-2010/)

---
JSON: https://onco.cc/api/v1/entities/piotr-rutkowski.json